6/21/2019 Contest update
Pfizer’s buyout bid for ARRY at a big premium brought multiple rays of sunshine to the biotech stock sector, almost doubling the Contest median’s YTD gain from the prior Friday.
At Friday’s close, the Contest median was up 19.37% YTD (vs. up 10.08% YTD a week earlier), the Nasdaq Biotech Index (NBI) was up 12.93% YTD (vs. up 6.32% YTD a week earlier) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 20.94% YTD (vs. up 13.03% YTD a week earlier), while the Nasdaq Composite Index (NCI) was up 21.05% YTD (vs. up 17.50% YTD a week earlier).
Contest leader BULBA’s portfolio was propelled to triple digit land, closing the week with a 102.08% YTD gain. KMASTR’s portfolio, up 68.73% YTD, vaulted into second place and ANDRE’s portfolio, up 68.23% YTD, held on to third place.
At Friday's close, 31 of the 39 Contest portfolios were in the green, while 25 were beating the NBI and 17 were beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 24.54% and a median YTD gain of 11.02%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe & relaxing first weekend of summer biotechies!
Peace & good health,
Bulba
6/21/19
Rank Name Profit/Loss
1 BULBA 102,080
2 KMASTR 68,727
3 ANDRE 68,231
4 OHMS 63,298
5 ARTHUR 60,504
6 BMAZ 60,176
7 HOOD 51,431
8 TRONKA 50,096
9 RKRW 43,155
10 BIOCQR 34,621
Week's Top 5 Gainers
Symbol 6/14/19 6/21/19 Wk.%chg.
ARRY 29.590 46.200 56.13%
DMAC 3.005 4.640 54.41%
ABUS 1.460 2.200 50.68%
AXGT 5.120 6.860 33.98%
BLU.TO 1.980 2.650 33.84%
Week's Worst 5 Losers
Symbol 6/14/19 6/21/19 Wk.%chg.
BHVN 62.980 41.060 -34.80%
SESN 1.700 1.440 -15.29%
ABEO 5.170 4.620 -10.64%
ADXS 2.500 2.240 -10.40%
PHM.MC 2.060 1.880 -8.74%
|
